Kwality [KPL] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison
Kwality
BSE
Loading...
Suven Life Sciences
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Kwality wins in 10 metrics, Suven Life Sciences wins in 8 metrics, with 0 ties. Kwality appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kwality | Suven Life Sciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.88 | -28.31 | Suven Life Sciences |
| Price-to-Book Ratio | 3.60 | 41.36 | Kwality |
| Debt-to-Equity Ratio | 42.85 | 0.00 | Suven Life Sciences |
| PEG Ratio | 0.51 | -0.34 | Suven Life Sciences |
| EV/EBITDA | 11.86 | -24.12 | Suven Life Sciences |
| Profit Margin (TTM) | 10.81% | 84.44% | Suven Life Sciences |
| Operating Margin (TTM) | 17.75% | -2,791.92% | Kwality |
| EBITDA Margin (TTM) | 17.75% | N/A | N/A |
| Return on Equity | 15.19% | -146.15% | Kwality |
| Return on Assets (TTM) | 8.91% | -118.91% | Kwality |
| Free Cash Flow (TTM) | $277.15M | $-1.91B | Kwality |
| 1-Year Return | 16.43% | 49.21% | Suven Life Sciences |
| Price-to-Sales Ratio (TTM) | 2.36 | 632.35 | Kwality |
| Enterprise Value | $10.46B | $44.90B | Suven Life Sciences |
| EV/Revenue Ratio | 2.60 | 597.31 | Kwality |
| Gross Profit Margin (TTM) | 47.94% | 100.00% | Suven Life Sciences |
| Revenue per Share (TTM) | $387 | $0 | Kwality |
| Earnings per Share (Diluted) | $41.81 | $-8.45 | Kwality |
| Beta (Stock Volatility) | -0.31 | 0.78 | Kwality |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Kwality vs Suven Life Sciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kwality | -4.97% | -0.40% | -2.23% | -20.74% | 17.55% | 6.68% |
| Suven Life Sciences | -2.18% | 3.79% | -10.27% | -21.82% | 76.25% | 63.70% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kwality | 16.43% | 111.98% | 1,447.16% | 4,012.00% | 4,012.00% | 4,012.00% |
| Suven Life Sciences | 49.21% | 215.69% | 329.98% | -26.12% | 600.33% | 3,806.72% |
News Based Sentiment: Kwality vs Suven Life Sciences
Kwality
News based Sentiment: MIXED
Kwality Pharmaceuticals reported impressive FY25 results, but Q1 FY26 showed a slight decline in income. While long-term performance remains strong and analysts are largely positive, the recent short-term weakness introduces some uncertainty, making the overall investment story mixed.
Suven Life Sciences
News based Sentiment: MIXED
October was a month of conflicting signals for Suven Life Sciences. While the company benefited from a positive pharmaceutical sector rally and maintained a debt-free status, it also reported continued quarterly losses and received a negative analyst rating. This creates a complex investment narrative with both potential opportunities and significant risks.
Performance & Financial Health Analysis: Kwality vs Suven Life Sciences
| Metric | KPL | SUVEN |
|---|---|---|
| Market Information | ||
| Market Cap | ₹10.00B | ₹47.99B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 10,178 | 184,111 |
| 90 Day Avg. Volume | 10,731 | 150,383 |
| Last Close | ₹879.25 | ₹204.83 |
| 52 Week Range | ₹596.05 - ₹1,235.00 | ₹102.50 - ₹299.99 |
| % from 52W High | -28.81% | -31.72% |
| All-Time High | ₹1,235.00 (Jul 07, 2025) | ₹338.50 (Apr 13, 2015) |
| % from All-Time High | -28.81% | -39.49% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.39% | 0.86% |
| Quarterly Earnings Growth | 0.43% | 0.86% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.84% |
| Operating Margin (TTM) | 0.18% | -27.92% |
| Return on Equity (TTM) | 0.15% | -1.46% |
| Debt to Equity (MRQ) | 42.85 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹254.23 | ₹5.04 |
| Cash per Share (MRQ) | ₹14.22 | ₹2.75 |
| Operating Cash Flow (TTM) | ₹387.34M | ₹-1,590,282,000 |
| Levered Free Cash Flow (TTM) | ₹398.45M | ₹-1,607,450,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Kwality vs Suven Life Sciences
| Metric | KPL | SUVEN |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.88 | -28.31 |
| Forward P/E | N/A | 10.78 |
| PEG Ratio | 0.51 | -0.34 |
| Price to Sales (TTM) | 2.36 | 632.35 |
| Price to Book (MRQ) | 3.60 | 41.36 |
| Market Capitalization | ||
| Market Capitalization | ₹10.00B | ₹47.99B |
| Enterprise Value | ₹10.46B | ₹44.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.60 | 597.31 |
| Enterprise to EBITDA | 11.86 | -24.12 |
| Risk & Other Metrics | ||
| Beta | -0.31 | 0.78 |
| Book Value per Share (MRQ) | ₹254.23 | ₹5.04 |
Financial Statements Comparison: Kwality vs Suven Life Sciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KPL | SUVEN |
|---|---|---|
| Revenue/Sales | ₹1.11B | ₹18.67M |
| Cost of Goods Sold | ₹580.34M | ₹0 |
| Gross Profit | ₹534.45M | ₹18.67M |
| Research & Development | N/A | ₹414.88M |
| Operating Income (EBIT) | ₹194.12M | ₹-521.17M |
| EBITDA | ₹245.52M | ₹-501.49M |
| Pre-Tax Income | ₹170.28M | ₹-515.17M |
| Income Tax | ₹51.08M | ₹0 |
| Net Income (Profit) | ₹119.20M | ₹-515.17M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KPL | SUVEN |
|---|---|---|
| Cash & Equivalents | ₹120.20M | ₹150.26M |
| Total Current Assets | ₹2.84B | ₹754.72M |
| Total Current Liabilities | ₹1.70B | ₹234.86M |
| Long-Term Debt | ₹151.19M | N/A |
| Total Shareholders Equity | ₹2.62B | ₹1.10B |
| Retained Earnings | ₹2.44B | ₹-6.01B |
| Property, Plant & Equipment | ₹458.28M | ₹756.69M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KPL | SUVEN |
|---|---|---|
| Operating Cash Flow | ₹-36.22M | N/A |
| Capital Expenditures | ₹-13.09M | N/A |
| Free Cash Flow | ₹-14.05M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KPL | SUVEN |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,178 | 184,111 |
| Average Daily Volume (90 Day) | 10,731 | 150,383 |
| Shares Outstanding | 10.38M | 218.07M |
| Float Shares | 2.30M | 67.61M |
| % Held by Insiders | 0.78% | 0.69% |
| % Held by Institutions | 0.00% | 0.02% |
Dividend Analysis & Yield Comparison: Kwality vs Suven Life Sciences
| Metric | KPL | SUVEN |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | ₹0.00 | ₹0.00 |
| Ex-Dividend Date | N/A | N/A |